Beryl Drugs Ltd.
Search Company
Income Statement  You can view the Income statement for the last 5 years.
ISIN No INE415H01017 52Wk High (Rs.) 30 BV (Rs.) 18.30 FV (Rs.) 10.00
Bookclosure 30/09/2024 52Wk Low (Rs.) 16 EPS (Rs.) 1.14 P/E (X) 16.13
Mkt Cap. (Rs. Cr.) 9.33 P/BV (X) 1.01 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]21.1526.7326.8914.6014.09
Total Operating Revenues21.1526.7326.8914.6014.09
      
Other Income1.410.400.270.160.19
Total Revenue22.5527.1227.1614.7714.28
      
EXPENSES     
Cost Of Materials Consumed11.1213.3114.238.717.45
Operating And Direct Expenses3.864.624.032.042.04
Changes In Inventories Of FG,WIP And Stock-In Trade-0.34-0.170.31-0.30-0.03
Employee Benefit Expenses2.211.931.701.311.18
Finance Costs0.530.460.420.440.47
Depreciation And Amortisation Expenses1.251.200.811.091.27
Other Expenses3.054.764.682.442.01
Total Expenses21.6926.1226.1715.7214.38
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax0.871.010.98-0.95-0.10
      
Exceptional Items0.000.000.000.000.45
Profit/Loss Before Tax0.871.010.98-0.950.35
      
Tax Expenses-Continued Operations     
Current Tax0.200.430.160.010.00
Deferred Tax0.10-0.200.06-0.300.11
Tax For Earlier Years-0.010.010.000.000.00
Total Tax Expenses0.290.240.22-0.290.11
Profit/Loss After Tax And Before ExtraOrdinary Items0.580.770.77-0.660.24
      
Profit/Loss From Continuing Operations0.580.770.77-0.660.24
      
Profit/Loss For The Period0.580.770.77-0.660.24
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)1.141.521.52-1.300.47
Diluted EPS (Rs.)1.141.521.52-1.300.47